関連レポート

出版元：QY Research  出版元について

発行年：2025年3月

定価：Single User License $4900 Multi User License $7350 Enterprise License $9800

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 148ページになります。

商品コード：QYR222

レポート紹介

ペプチドワクチンの世界市場は、2024年の１億1452万ドルから2031年には1億8930万ドルに成長し、予測期間中の年間平均成長率（CAGR）は7.36％と予測されています。
当レポートでは、ペプチドワクチンの市場予測-2031年、各種セグメント別市場分析(タイプ別、用途別、国地域別、等)、企業別分析などの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■ペプチドワクチンの世界市場予測2025-2031年
・市場規模(US$)
・量ベース（Litre）

■企業別分析
United Biomedical
CAHIC
Xinjiang Tecon
ISA Pharmaceuticals
Lytix Biopharma
Merck
オンコセラピー・サイエンス株式会社
Circio
Stemline Therapeutics
Treos Bio

■タイプ別市場
FMD タイプ O
FMDタイプ O+A
その他

■用途別市場
政府調達
直接販売

■国地域別市場
北米＆カナダ
・米国
・カナダ
・メキシコ

・中国

アジア太平洋（中国を除く）
・日本
・韓国
・台湾
・東南アジア
・インド
・オーストラリア
ヨーロッパ
・ドイツ
・フランス
・英国
・イタリア
・ロシア
中東、アフリカ、中南米

（全148頁）

Table of Contents (英文詳細目次）

1 STUDY COVERAGE 1
1.1 Synthetic Peptide Vaccine Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 1
1.2.2 FMD Type O 4
1.2.3 FMD Type O+A 4
1.2.4 Others 5
1.3 Market by Application 5
1.3.1 Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 5
1.3.2 Government Procurement 7
1.3.3 Direct Sales 8
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10

2 EXECUTIVE SUMMARY 11
2.1 Global Synthetic Peptide Vaccine Revenue Estimates and Forecasts 2020-2031 11
2.2 Global Synthetic Peptide Vaccine Revenue by Region 12
2.2.1 Global Synthetic Peptide Vaccine Revenue by Region: 2020 VS 2024 VS 2031 12
2.2.2 Global Synthetic Peptide Vaccine Revenue by Region (2020-2025) 14
2.2.3 Global Synthetic Peptide Vaccine Revenue by Region (2026-2031) 15
2.2.4 Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2031) 15
2.3 Global Synthetic Peptide Vaccine Sales Estimates and Forecasts 2020-2031 17
2.4 Global Synthetic Peptide Vaccine Sales by Region 17
2.4.1 Global Synthetic Peptide Vaccine Sales by Region: 2020 VS 2024 VS 2031 17
2.4.2 Global Synthetic Peptide Vaccine Sales by Region (2020-2025) 18
2.4.3 Global Synthetic Peptide Vaccine Sales by Region (2026-2031) 19
2.4.4 Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2031) 19
2.5 US & Canada 21
2.6 Europe 22
2.7 China 23
2.8 Asia (excluding China) 24
2.9 Middle East, Africa and Latin America 25

3 COMPETITION BY MANUFACTURERS 26
3.1 Global Synthetic Peptide Vaccine Sales by Manufacturers 26
3.1.1 Global Synthetic Peptide Vaccine Sales by Manufacturers (2020-2025) 26
3.1.2 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2020-2025) 26
3.2 Global Synthetic Peptide Vaccine Revenue by Manufacturers 27
3.2.1 Global Synthetic Peptide Vaccine Revenue by Manufacturers (2020-2025) 27
3.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025) 28
3.3 Global Key Players of Synthetic Peptide Vaccine, Industry Ranking in 2024 29
3.4 Global Synthetic Peptide Vaccine Sales Price by Manufacturers (2020-2025) 29
3.5 Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Base Distribution and Headquarters 29
3.6 Global Key Manufacturers of Synthetic Peptide Vaccine, Product Offered 30
3.7 Global Key Manufacturers of Synthetic Peptide Vaccine, Founded Date 31
3.8 Mergers & Acquisitions, Expansion Plans 31

4 MARKET SIZE BY TYPE 33
4.1 Global Synthetic Peptide Vaccine Sales by Type 33
4.1.1 Global Synthetic Peptide Vaccine Historical Sales by Type (2020-2025) 33
4.1.2 Global Synthetic Peptide Vaccine Forecasted Sales by Type (2026-2031) 33
4.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Type (2020-2031) 34
4.2 Global Synthetic Peptide Vaccine Revenue by Type 35
4.2.1 Global Synthetic Peptide Vaccine Historical Revenue by Type (2020-2025) 35
4.2.2 Global Synthetic Peptide Vaccine Forecasted Revenue by Type (2026-2031) 36
4.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2020-2031) 36
4.3 Global Synthetic Peptide Vaccine Price by Type 37
4.3.1 Global Synthetic Peptide Vaccine Price by Type (2020-2025) 37
4.3.2 Global Synthetic Peptide Vaccine Price Forecast by Type (2026-2031) 38

5 MARKET SIZE BY APPLICATION 39
5.1 Global Synthetic Peptide Vaccine Sales by Application 39
5.1.1 Global Synthetic Peptide Vaccine Historical Sales by Application (2020-2025) 39
5.1.2 Global Synthetic Peptide Vaccine Forecasted Sales by Application (2026-2031) 39
5.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Application (2020-2031) 40
5.2 Global Synthetic Peptide Vaccine Revenue by Application 41
5.2.1 Global Synthetic Peptide Vaccine Historical Revenue by Application (2020-2025) 41
5.2.2 Global Synthetic Peptide Vaccine Forecasted Revenue by Application (2026-2031) 41
5.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2020-2031) 41
5.3 Global Synthetic Peptide Vaccine Price by Application 43
5.3.1 Global Synthetic Peptide Vaccine Price by Application (2020-2025) 43
5.3.2 Global Synthetic Peptide Vaccine Price Forecast by Application (2026-2031) 43

6 US & CANADA 44
6.1 US & Canada Synthetic Peptide Vaccine Market Size by Type 44
6.1.1 US & Canada Synthetic Peptide Vaccine Sales by Type (2020-2031) 44
6.1.2 US & Canada Synthetic Peptide Vaccine Revenue by Type (2020-2031) 45
6.2 US & Canada Synthetic Peptide Vaccine Market Size by Application 46
6.2.1 US & Canada Synthetic Peptide Vaccine Sales by Application (2020-2031) 46
6.2.2 US & Canada Synthetic Peptide Vaccine Revenue by Application (2020-2031) 47
6.3 US & Canada Synthetic Peptide Vaccine Market Size by Country 48
6.3.1 US & Canada Synthetic Peptide Vaccine Revenue by Country (2020-2031) 48
6.3.2 US & Canada Synthetic Peptide Vaccine Sales by Country (2020-2031) 50
6.3.3 US 51
6.3.4 Canada 51
6.3.5 Mexico 52

7 EUROPE 53
7.1 Europe Synthetic Peptide Vaccine Market Size by Type 53
7.1.1 Europe Synthetic Peptide Vaccine Sales by Type (2020-2031) 53
7.1.2 Europe Synthetic Peptide Vaccine Revenue by Type (2020-2031) 54
7.2 Europe Synthetic Peptide Vaccine Market Size by Application 55
7.2.1 Europe Synthetic Peptide Vaccine Sales by Application (2020-2031) 55
7.2.2 Europe Synthetic Peptide Vaccine Revenue by Application (2020-2031) 56
7.3 Europe Synthetic Peptide Vaccine Market Size by Country 57
7.3.1 Europe Synthetic Peptide Vaccine Revenue by Country (2020-2031) 57
7.3.2 Europe Synthetic Peptide Vaccine Sales by Country (2020-2031) 58
7.3.3 Germany 60
7.3.4 France 60
7.3.5 U.K. 61
7.3.6 Italy 61
7.3.7 Russia 62

8 CHINA 63
8.1 China Synthetic Peptide Vaccine Market Size by Type 63
8.1.1 China Synthetic Peptide Vaccine Sales by Type (2020-2031) 63
8.1.2 China Synthetic Peptide Vaccine Revenue by Type (2020-2031) 64
8.2 China Synthetic Peptide Vaccine Market Size by Application 65
8.2.1 China Synthetic Peptide Vaccine Sales by Application (2020-2031) 65
8.2.2 China Synthetic Peptide Vaccine Revenue by Application (2020-2031) 66

9 ASIA (EXCLUDING CHINA) 68
9.1 Asia Synthetic Peptide Vaccine Market Size by Type 68
9.1.1 Asia Synthetic Peptide Vaccine Sales by Type (2020-2031) 68
9.1.2 Asia Synthetic Peptide Vaccine Revenue by Type (2020-2031) 69
9.2 Asia Synthetic Peptide Vaccine Market Size by Application 70
9.2.1 Asia Synthetic Peptide Vaccine Sales by Application (2020-2031) 70
9.2.2 Asia Synthetic Peptide Vaccine Revenue by Application (2020-2031) 71
9.3 Asia Synthetic Peptide Vaccine Market Size by Region 72
9.3.1 Asia Synthetic Peptide Vaccine Revenue by Region (2020-2031) 72
9.3.2 Asia Synthetic Peptide Vaccine Sales by Region (2020-2031) 73
9.3.3 Japan 75
9.3.4 South Korea 75
9.3.5 China Taiwan 76
9.3.6 Southeast Asia 76
9.3.7 India 77

10 MIDDLE EAST, AFRICA AND LATIN AMERICA 78
10.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Type 78
10.1.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2020-2031) 78
10.1.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2020-2031) 79
10.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Application 80
10.2.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2020-2031) 80
10.2.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2020-2031) 81
10.3 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Country 83
10.3.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2020-2031) 83
10.3.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2020-2031) 84
10.3.3 Latin America 86
10.3.4 Middle East 86
10.3.5 Africa 87

11 CORPORATE PROFILE 88
11.1 United Biomedical 88
11.1.1 United Biomedical Company Information 88
11.1.2 United Biomedical Overview 88
11.1.3 United Biomedical Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025) 91
11.1.4 United Biomedical Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 91
11.1.5 United Biomedical Recent Developments 94
11.2 CAHIC 95
11.2.1 CAHIC Company Information 95
11.2.2 CAHIC Overview 95
11.2.3 CAHIC Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025) 96
11.2.4 CAHIC Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 96
11.3 Xinjiang Tecon 97
11.3.1 Xinjiang Tecon Company Information 97
11.3.2 Xinjiang Tecon Overview 97
11.3.3 Xinjiang Tecon Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025) 98
11.3.4 Xinjiang Tecon Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 98
11.4 ISA Pharmaceuticals 99
11.4.1 ISA Pharmaceuticals Company Information 99
11.4.2 ISA Pharmaceuticals Overview 99
11.4.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 100
11.5 Lytix Biopharma 101
11.5.1 Lytix Biopharma Company Information 101
11.5.2 Lytix Biopharma Overview 101
11.5.3 Lytix Biopharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 102
11.6 Merck 103
11.6.1 Merck Company Information 103
11.6.2 Merck Overview 103
11.6.3 Merck Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 104
11.7 OncoTherapy Science 104
11.7.1 OncoTherapy Science Company Information 104
11.7.2 OncoTherapy Science Overview 105
11.7.3 OncoTherapy Science Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 105
11.8 Circio 106
11.8.1 Circio Company Information 106
11.8.2 Circio Overview 107
11.8.3 Circio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 107
11.8.4 Circio Recent Developments 108
11.9 Stemline Therapeutics 108
11.9.1 Stemline Therapeutics Company Information 108
11.9.2 Stemline Therapeutics Overview 109
11.9.3 Stemline Therapeutics Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 109
11.10 Treos Bio 110
11.10.1 Treos Bio Company Information 110
11.10.2 Treos Bio Overview 111
11.10.3 Treos Bio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 111

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 114
12.1 Synthetic Peptide Vaccine Industry Chain Analysis 114
12.2 Synthetic Peptide Vaccine Key Raw Material 114
12.2.1 Key Raw Materials 114
12.2.2 Raw Materials Key Suppliers 114
12.3 Synthetic Peptide Vaccine Production Mode & Process 115
12.4 Synthetic Peptide Vaccine Sales and Marketing 116

13 SYNTHETIC PEPTIDE VACCINE MARKET DYNAMICS 117
13.1.1 Synthetic Peptide Vaccine Industry Trends 117
13.1.2 Synthetic Peptide Vaccine Market Drivers 117
13.1.3 Synthetic Peptide Vaccine Market Challenges 118
13.1.4 Synthetic Peptide Vaccine Market Restraints 119

14 KEY FINDINGS IN THE GLOBAL SYNTHETIC PEPTIDE VACCINE STUDY 120

15 APPENDIX 121
15.1 Research Methodology 121
15.1.1 Methodology/Research Approach 121
15.1.2 Data Source 124
15.2 Author Details 126
15.3 Disclaimer 127

Table 1. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million) 2
Table 2. Major Manufacturers of FMD Type O 4
Table 3. Major Manufacturers of FMD Type O+A 5
Table 4. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million) 5
Table 5. Global Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million) 13
Table 6. Global Synthetic Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million) 14
Table 7. Global Synthetic Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million) 15
Table 8. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2025) 15
Table 9. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2026-2031) 16
Table 10. Global Synthetic Peptide Vaccine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M ml) 17
Table 11. Global Synthetic Peptide Vaccine Sales by Region (2020-2025) & (M ml) 18
Table 12. Global Synthetic Peptide Vaccine Sales by Region (2026-2031) & (M ml) 19
Table 13. Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2025) 19
Table 14. Global Synthetic Peptide Vaccine Sales Market Share by Region (2026-2031) 19
Table 15. Global Synthetic Peptide Vaccine Sales by Manufacturers (2020-2025) & (M ml) 26
Table 16. Global Synthetic Peptide Vaccine Sales Share by Manufacturers (2020-2025) 26
Table 17. Global Synthetic Peptide Vaccine Revenue by Manufacturers (2020-2025) & (US$ Million) 28
Table 18. Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025) 28
Table 19. Global Key Players of Synthetic Peptide Vaccine, Industry Ranking in 2024 29
Table 20. Synthetic Peptide Vaccine Price by Manufacturers (2020-2025) & (USD/Litre) 29
Table 21. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Base Distribution and Headquarters 30
Table 22. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Offered 30
Table 23. Global Key Manufacturers of Synthetic Peptide Vaccine, Founded Date 31
Table 24. Mergers & Acquisitions, Expansion Plans 31
Table 25. Global Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml) 33
Table 26. Global Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml) 33
Table 27. Global Synthetic Peptide Vaccine Sales Share by Type (2020-2025) 34
Table 28. Global Synthetic Peptide Vaccine Sales Share by Type (2026-2031) 34
Table 29. Global Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million) 35
Table 30. Global Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million) 36
Table 31. Global Synthetic Peptide Vaccine Revenue Share by Type (2020-2025) 36
Table 32. Global Synthetic Peptide Vaccine Revenue Share by Type (2026-2031) 36
Table 33. Synthetic Peptide Vaccine Price by Type (2020-2025) & (USD/Litre) 37
Table 34. Global Synthetic Peptide Vaccine Price Forecast by Type (2026-2031) & (USD/Litre) 38
Table 35. Global Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml) 39
Table 36. Global Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml) 39
Table 37. Global Synthetic Peptide Vaccine Sales Share by Application (2020-2025) 40
Table 38. Global Synthetic Peptide Vaccine Sales Share by Application (2026-2031) 40
Table 39. Global Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million) 41
Table 40. Global Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million) 41
Table 41. Global Synthetic Peptide Vaccine Revenue Share by Application (2020-2025) 41
Table 42. Global Synthetic Peptide Vaccine Revenue Share by Application (2026-2031) 42
Table 43. Synthetic Peptide Vaccine Price by Application (2020-2025) & (USD/Litre) 43
Table 44. Global Synthetic Peptide Vaccine Price Forecast by Application (2026-2031) & (USD/Litre) 43
Table 45. US & Canada Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml) 44
Table 46. US & Canada Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml) 44
Table 47. US & Canada Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million) 45
Table 48. US & Canada Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million) 45
Table 49. US & Canada Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml) 46
Table 50. US & Canada Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml) 47
Table 51. US & Canada Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million) 47
Table 52. US & Canada Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million) 48
Table 53. US & Canada Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million) 48
Table 54. US & Canada Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million) 49
Table 55. US & Canada Synthetic Peptide Vaccine Sales by Country (2020-2025) & (M ml) 50
Table 56. US & Canada Synthetic Peptide Vaccine Sales by Country (2026-2031) & (M ml) 50
Table 57. Europe Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml) 53
Table 58. Europe Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml) 53
Table 59. Europe Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million) 54
Table 60. Europe Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million) 54
Table 61. Europe Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml) 55
Table 62. Europe Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml) 55
Table 63. Europe Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million) 56
Table 64. Europe Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million) 56
Table 65. Europe Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million) 57
Table 66. Europe Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million) 58
Table 67. Europe Synthetic Peptide Vaccine Sales by Country (2020-2025) & (M ml) 58
Table 68. Europe Synthetic Peptide Vaccine Sales by Country (2026-2031) & (M ml) 59
Table 69. China Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml) 63
Table 70. China Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml) 63
Table 71. China Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million) 64
Table 72. China Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million) 64
Table 73. China Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml) 65
Table 74. China Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml) 65
Table 75. China Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million) 66
Table 76. China Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million) 66
Table 77. Asia Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml) 68
Table 78. Asia Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml) 68
Table 79. Asia Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million) 69
Table 80. Asia Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million) 69
Table 81. Asia Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml) 70
Table 82. Asia Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml) 70
Table 83. Asia Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million) 71
Table 84. Asia Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million) 71
Table 85. Asia Synthetic Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million) 72
Table 86. Asia Synthetic Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million) 73
Table 87. Asia Synthetic Peptide Vaccine Sales by Region (2020-2025) & (M ml) 73
Table 88. Asia Synthetic Peptide Vaccine Sales by Region (2026-2031) & (M ml) 74
Table 89. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml) 78
Table 90. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2026-2031) & (M ml) 78
Table 91. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2020-2025) & (US$ Million) 79
Table 92. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2026-2031) & (US$ Million) 79
Table 93. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml) 80
Table 94. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2026-2031) & (M ml) 81
Table 95. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2020-2025) & (US$ Million) 81
Table 96. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2026-2031) & (US$ Million) 82
Table 97. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million) 83
Table 98. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million) 83
Table 99. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2020-2025) & (M ml) 84
Table 100. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2026-2031) & (M ml) 84
Table 101. United Biomedical Company Information 88
Table 102. United Biomedical Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2020-2025) 91
Table 103. United Biomedical Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 91
Table 104. United Biomedical Recent Developments 94
Table 105. CAHIC Company Information 95
Table 106. CAHIC Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2020-2025) 96
Table 107. CAHIC Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 96
Table 108. Xinjiang Tecon Company Information 97
Table 109. Xinjiang Tecon Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2020-2025) 98
Table 110. Xinjiang Tecon Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 98
Table 111. ISA Pharmaceuticals Company Information 99
Table 112. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 100
Table 113. Lytix Biopharma Company Information 101
Table 114. Lytix Biopharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 102
Table 115. Merck Company Information 103
Table 116. Merck Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 104
Table 117. OncoTherapy Science Company Information 104
Table 118. OncoTherapy Science Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 105
Table 119. Circio Company Information 106
Table 120. Circio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 107
Table 121. Circio Recent Developments 108
Table 122. Stemline Therapeutics Company Information 108
Table 123. Stemline Therapeutics Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 109
Table 124. Treos Bio Company Information 110
Table 125. Treos Bio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 111
Table 126. Raw Materials Key Suppliers Lists 114
Table 127. Synthetic Peptide Vaccine Market Trends 117
Table 128. Synthetic Peptide Vaccine Market Drivers 117
Table 129. Synthetic Peptide Vaccine Market Challenges 118
Table 130. Synthetic Peptide Vaccine Market Restraints 119
Table 131. Research Programs/Design for This Report 121
Table 132. Key Data Information from Secondary Sources 124
Table 133. Key Data Information from Primary Sources 125

List of Figures

Figure 1. Synthetic Peptide Vaccine Product Picture 1
Figure 2. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million) 2
Figure 3. Global Synthetic Peptide Vaccine Market Share by Type: 2024 & 2031 3
Figure 4. FMD Type O Product Picture 4
Figure 5. FMD Type O+A Product Picture 5
Figure 6. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million) 6
Figure 7. Global Synthetic Peptide Vaccine Market Share by Application: 2024 & 2031 7
Figure 8. Synthetic Peptide Vaccine Report Years Considered 10
Figure 9. Global Synthetic Peptide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031 11
Figure 10. Global Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 12
Figure 11. Global Synthetic Peptide Vaccine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million) 13
Figure 12. Global Synthetic Peptide Vaccine Revenue Market Share by Region in Percentage: 2024 Versus 2031 14
Figure 13. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2031) 16
Figure 14. Global Synthetic Peptide Vaccine Sales (2020-2031) & (M ml) 17
Figure 15. Global Synthetic Peptide Vaccine Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (M ml) 18
Figure 16. Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2031) 20
Figure 17. US & Canada Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml) 21
Figure 18. US & Canada Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million) 21
Figure 19. Europe Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml) 22
Figure 20. Europe Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million) 22
Figure 21. China Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml) 23
Figure 22. China Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million) 23
Figure 23. Asia (excluding China) Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml) 24
Figure 24. Asia (excluding China) Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million) 24
Figure 25. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales YoY (2020-2031) & (M ml) 25
Figure 26. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue YoY (2020-2031) & (US$ Million) 25
Figure 27. Global Synthetic Peptide Vaccine Sales Share by Manufacturers (2024) 27
Figure 28. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2024) 28
Figure 29. Global Synthetic Peptide Vaccine Sales Market Share by Type (2020-2031) 35
Figure 30. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2020-2031) 37
Figure 31. Global Synthetic Peptide Vaccine Sales Market Share by Application (2020-2031) 40
Figure 32. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2020-2031) 42
Figure 33. US & Canada Synthetic Peptide Vaccine Sales Market Share by Type 2024 45
Figure 34. US & Canada Synthetic Peptide Vaccine Revenue Market Share by Type 2024 46
Figure 35. US & Canada Synthetic Peptide Vaccine Sales Market Share by Application 2024 47
Figure 36. US & Canada Synthetic Peptide Vaccine Revenue Market Share by Application 2024 48
Figure 37. US & Canada Synthetic Peptide Vaccine Revenue Share by Country 2024 49
Figure 38. US & Canada Synthetic Peptide Vaccine Sales Share by Country 2024 50
Figure 39. US Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 51
Figure 40. Canada Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 51
Figure 41. Mexico Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 52
Figure 42. Europe Synthetic Peptide Vaccine Sales Market Share by Type 2024 54
Figure 43. Europe Synthetic Peptide Vaccine Revenue Market Share by Type 2024 55
Figure 44. Europe Synthetic Peptide Vaccine Sales Market Share by Application 2024 56
Figure 45. Europe Synthetic Peptide Vaccine Revenue Market Share by Application 2024 57
Figure 46. Europe Synthetic Peptide Vaccine Revenue Share by Country 2024 58
Figure 47. Europe Synthetic Peptide Vaccine Sales Share by Country 2024 59
Figure 48. Germany Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 60
Figure 49. France Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 60
Figure 50. U.K. Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 61
Figure 51. Italy Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 61
Figure 52. Russia Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 62
Figure 53. China Synthetic Peptide Vaccine Sales Market Share by Type 2024 64
Figure 54. China Synthetic Peptide Vaccine Revenue Market Share by Type 2024 65
Figure 55. China Synthetic Peptide Vaccine Sales Market Share by Application 2024 66
Figure 56. China Synthetic Peptide Vaccine Revenue Market Share by Application 2024 67
Figure 57. Asia Synthetic Peptide Vaccine Sales Market Share by Type 2024 69
Figure 58. Asia Synthetic Peptide Vaccine Revenue Market Share by Type 2024 70
Figure 59. Asia Synthetic Peptide Vaccine Sales Market Share by Application 2024 71
Figure 60. Asia Synthetic Peptide Vaccine Revenue Market Share by Application 2024 72
Figure 61. Asia Synthetic Peptide Vaccine Revenue Share by Region 2024 73
Figure 62. Asia Synthetic Peptide Vaccine Sales Share by Region 2024 74
Figure 63. Japan Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 75
Figure 64. South Korea Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 75
Figure 65. China Taiwan Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 76
Figure 66. Southeast Asia Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 76
Figure 67. India Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 77
Figure 68. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Market Share by Type 2024 79
Figure 69. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Market Share by Type 2024 80
Figure 70. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Market Share by Application 2024 81
Figure 71. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Market Share by Application 2024 82
Figure 72. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Share by Country 2024 84
Figure 73. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Share by Country 2024 85
Figure 74. Latin America Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 86
Figure 75. Middle East Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 86
Figure 76. Africa Synthetic Peptide Vaccine Revenue (2020-2031) & (US$ Million) 87
Figure 77. UBI Group Of Companies 89
Figure 78. UBI Group Has Three Development Platforms 90
Figure 79. Synthetic Peptide Vaccine Value Chain 114
Figure 80. Bottom-up and Top-down Approaches for This Report 123
Figure 81. Data Triangulation 124
Figure 82. Key Executives Interviewed 126

△ 一番上に戻る